CXCL8 and colorectal carcinoma: TAMs can significantly upregulate the vascular endothelial growth factor-A (VEGF-A) of CRC cells and activate the NF-κB signaling pathway by secreting IL-6 and IL-8, promoting CRC metastasis (77).